| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/29/2006 | US7098331 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/29/2006 | US7098231 Viral polymerase inhibitors |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7097706 non-calcined clay composite includes clay, lime, blast furnace slag, alkaline chemical, and water in specified amounts, and has high compression strength due to an ionic coagulation reaction, a pozzolan reaction, and a latent hydraulic reaction |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006088921A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088919A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088711A1 AZOLYLACYLGUANIDINES AS β-SECRETASE INHIBITORS |
| 08/24/2006 | WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative |
| 08/24/2006 | WO2006087355A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | WO2006087143A1 Novel processes for the preparation of a 2h-chromene |
| 08/24/2006 | WO2006087140A1 Novell processes for the preparation of a benzofuran |
| 08/24/2006 | WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors |
| 08/24/2006 | WO2006056850A3 Chroman compounds |
| 08/24/2006 | WO2006035067A3 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 08/24/2006 | WO2005090333A8 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189673 Phenylazole compound, production process therefor and antioxidant |
| 08/24/2006 | US20060189672 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 08/24/2006 | US20060189664 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 08/24/2006 | US20060189663 Pyrrole-2,5-dithione derivatives as liver x receptor modulators |
| 08/24/2006 | US20060189650 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189645 Novel 6-phenylphenantridines |
| 08/24/2006 | US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 08/24/2006 | US20060189629 N-(2-morpholin-4-ylethyl)-1-(4-{[4-(trifluoromethoxy)benzyl]oxy}phenyl)-1H -benzimidazole-5-carboxamide; c-Kit proto-oncogene (stem cell factor receptor) anhibitor; tyrosine kinase inhibitor; antiproliferative, anticarcinogenic agent; |
| 08/24/2006 | US20060189622 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations |
| 08/24/2006 | US20060189621 Benzofuran derivative |
| 08/24/2006 | US20060189614 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection |
| 08/24/2006 | US20060189613 Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4) |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189577 Tyrosine kinase inhibitors |
| 08/24/2006 | US20060188943 For ultrahigh throughput assays; combinatorial libraries; solid phase synthesis; drug screening |
| 08/24/2006 | US20060188915 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 08/24/2006 | CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598458A1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598457A1 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | CA2597594A1 Azolylacylguanidines as beta-secretase inhibitors |
| 08/24/2006 | CA2596669A1 Novel processes for the preparation of a 2h-chromene |
| 08/24/2006 | CA2596668A1 Novel processes for the preparation of a benzofuran |
| 08/23/2006 | EP1693373A1 Enantiomerically pure beta-D-(-)-dioxolane-nucleosides |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1693358A1 Process for producing epoxytriazole compound and intermediate therefor |
| 08/23/2006 | EP1692502A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1692116A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 08/23/2006 | EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 08/23/2006 | EP1692113A1 Aryl imidazoles and their use as anti-cancer agents |
| 08/23/2006 | EP1692111A2 Quinolines useful in treating cardiovascular disease |
| 08/23/2006 | EP1692109A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 08/23/2006 | EP1692108A1 Novel herbicides |
| 08/23/2006 | EP1692085A2 Inhibition of fgfr3 and treatment of multiple myeloma |
| 08/23/2006 | EP1691810A1 Substituted piperazines |
| 08/23/2006 | EP1691803A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 08/23/2006 | EP1490350B1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 08/23/2006 | EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/23/2006 | EP1244646B1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same |
| 08/23/2006 | EP1027328B1 Substituted anilides |
| 08/23/2006 | CN1823063A Quinoline derivatives as phosphodiesterase inhibitors |
| 08/23/2006 | CN1823061A Pyrrole-2, 5-dione derivatives as liver X receptor modulators |
| 08/23/2006 | CN1823056A Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto |
| 08/23/2006 | CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 08/23/2006 | CN1821242A Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor |
| 08/23/2006 | CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/23/2006 | CN1821236A Therapeutic heterocyclic compounds |
| 08/23/2006 | CN1271068C Novel method for preparing olmesartan |
| 08/23/2006 | CN1271063C Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094900 N-Aryl-2-oxazolidinones and their derivatives |
| 08/22/2006 | US7094897 Rhodium and iridium complexes |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094791 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 08/22/2006 | CA2242102C Quinazoline derivatives as antitumor agents |
| 08/17/2006 | WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | WO2006085685A1 Pyrazole compound |
| 08/17/2006 | WO2006066950A3 Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents |
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2006031782A3 Salvinorin derivatives as opioid receptor ligands |
| 08/17/2006 | WO2006002383A3 2-aminoarylcarboxamides useful as cancer chemotherapeutic agents |
| 08/17/2006 | WO2005089813A3 Receptor-avid exogenous optical contrast and therapeutic agents |
| 08/17/2006 | WO2005086895A3 Ion channel modulators |